Diagnostic value of a semi-nested PCR for the diagnosis of mucormycosis and aspergillosis from paraffin-embedded tissue: A single center experience.

[1]  V. Deshpande,et al.  General Principles in the Diagnosis of Infection , 2017, Diagnostic Pathology of Infectious Disease.

[2]  G. Alangaden,et al.  Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. , 2016, Infectious disease clinics of North America.

[3]  E. Poeschla,et al.  Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high‐risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin‐amphotericin combination therapies , 2014, Mycoses.

[4]  C. Lass‐Flörl,et al.  Laboratory diagnosis of mucormycosis: current status and future perspectives. , 2014, Future Microbiology.

[5]  L. Pagano,et al.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  L. Pagano,et al.  ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[7]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  M. J. Buitrago,et al.  Performance of Panfungal- and Specific-PCR-Based Procedures for Etiological Diagnosis of Invasive Fungal Diseases on Tissue Biopsy Specimens with Proven Infection: a 7-Year Retrospective Analysis from a Reference Laboratory , 2014, Journal of Clinical Microbiology.

[9]  Russell E. Lewis,et al.  Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study , 2013, Mycoses.

[10]  L. Pagano,et al.  Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3) , 2013, Haematologica.

[11]  D. Kontoyiannis,et al.  Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model of Aspergillus fumigatus-Rhizopus oryzae pulmonary infection , 2011, Virulence.

[12]  D. Milner,et al.  Molecular Methods To Improve Diagnosis and Identification of Mucormycosis , 2011, Journal of Clinical Microbiology.

[13]  G. Alangaden.  Nosocomial fungal infections: epidemiology, infection control, and prevention. , 2011, Infectious disease clinics of North America.

[14]  Zuotao Zhao,et al.  Simultaneous Detection and Identification of Aspergillus and Mucorales Species in Tissues Collected from Patients with Fungal Rhinosinusitis , 2011, Journal of Clinical Microbiology.

[15]  V. Saegeman,et al.  Increasing Incidence of Mucormycosis in University Hospital, Belgium , 2010, Emerging infectious diseases.

[16]  Thomas J Walsh,et al.  Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  J. Desenclos,et al.  Increasing Incidence of Zygomycosis (Mucormycosis), France, 1997–2006 , 2009, Emerging infectious diseases.

[18]  C. Lass‐Flörl,et al.  Changing epidemiology of systemic fungal infections. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  Raoul Herbrecht,et al.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  L. Pagano,et al.  Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  G. Petrikkos,et al.  Recent advances in antifungal chemotherapy. , 2007, International journal of antimicrobial agents.

[22]  Michael Worobey,et al.  The Isolation of Nucleic Acids from Fixed, Paraffin-Embedded Tissues–Which Methods Are Useful When? , 2007, PloS one.

[23]  M. Rinaldi,et al.  In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents , 2007, Antimicrobial Agents and Chemotherapy.

[24]  V. Rickerts,et al.  Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[25]  V. Rickerts,et al.  PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue , 2005, Journal of Clinical Pathology.

[26]  D. Kontoyiannis,et al.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  Russell E. Lewis,et al.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.

[28]  S. M. Svoboda-Newman,et al.  Comparison of Methods for Extracting DNA from Formalin‐Fixed Paraffin Sections for Nonisotopic PCR , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[29]  G. Samonis,et al.  Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices? , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[30]  E. Mellado,et al.  In vitro activity of antifungals against Zygomycetes. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  L. Pagano,et al.  Design and Methods , 2022 .